Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a Body Corporate”

252 pharma patents match "The Regents of the University of Colorado, a Body Corporate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 3 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "The Regents of the University of Colorado, a Body Corporate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “The Regents of the University of Colorado, a Body Corporate” · 30,257 patents in full index Clear search

  1. US 11376311

    Methods of treating microbial infection and inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  2. US 11324811

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 10, 2022 · Expires May 5, 2042

    granted

  3. US 11304996

    Yeast-based immunotherapy and type I interferon sensitivity

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  4. US 11298441

    Biodegradable biomimetics of growth plate cartilage for the treatment of physeal injuries

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  5. US 11273127

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  6. US 11267859

    GM-CSF mimetics and methods of making and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  7. US 11253506

    Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  8. US 11219552

    Intraocular filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  9. US 11207211

    Lacrimal drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  10. US 11185580

    Compositions, methods and uses for improved human papilloma virus constructs

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  11. US 11181536

    Methods for monitoring treatment of chronic liver disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  12. US 11169142

    Viscoelastic analysis in patients with disease associated with cardiovascular system

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  13. US 11160908

    Intraocular drug delivery and filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  14. US 11155821

    Compositions and methods for tagging ribonucleic acids

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  15. US 11147946

    Venous access catheters and methods for portal venous system catheterization

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  16. US 11137409

    Identification of novel disease states using viscoelastic analysis in the presence of a thrombolytic agent

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  17. US 11110080

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  18. US 11083720

    Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  19. US 11077175

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  20. US 11052060

    Compounds and methods for treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  21. US 11033601

    Selective inhibition of V1b for treating fatty liver

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  22. US 11013707

    Administration of oral methyldopa

    The Regents of the University of Colorado, a Body Corporate · Granted May 25, 2021 · Expires May 20, 2041

    granted

  23. US 10993834

    Lacrimal system drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  24. US 10947238

    Wee1 kinase inhibitors and methods of making and using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.